These novel treatments, Tirzepatide , represent a remarkable advancement in addressing metabolic dysfunction and possibly associated conditions . They are categorized as GLP-1 hormone activators , https://haseebcxhl608986.ampedpages.com/tirzepatide-a-thorough-dive-into-incretin-agents-68478487